Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
11.20
+1.16 (11.55%)
At close: Aug 13, 2025, 4:00 PM
11.20
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:10 PM EDT
Aardvark Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$33.00
Upside
+194.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +257.14% | Jun 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +78.57% | May 15, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +87.50% | Apr 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +346.43% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $26 | Strong Buy | Maintains | $22 → $26 | +132.14% | Mar 27, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $21 | Buy | Initiates | $21 | +87.50% | Mar 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $50 | Buy | Initiates | $50 | +346.43% | Mar 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $29 | Buy | Initiates | $29 | +158.93% | Mar 10, 2025 |
| B of A Securities | B of A Securities | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +96.43% | Mar 10, 2025 |